首页> 美国卫生研究院文献>Hand (New York N.Y.) >Complications Following Collagenase Treatment for Dupuytren Contracture
【2h】

Complications Following Collagenase Treatment for Dupuytren Contracture

机译:胶原酶治疗Dupuytren挛缩后的并发症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Collagenase Clostridium histolyticum (CCH) injection and manipulation is a relatively new method for treating Dupuytren contracture that is growing in popularity. Although side effects such as swelling and ecchymosis are common, they are typically mild and self-limited. Major complications are rare but have included flexor tendon rupture and complex regional pain syndrome. >Methods: This study describes a case report of 2 patients seen at our institution. >Results: Here, we report 2 patients seen at our institution each with different, yet serious complications after CCH injection and manipulation. One patient had extensive skin loss and chose amputation over reconstruction. The other patient had loss of perfusion and required finger amputation. >Conclusions: Although it is unclear how directly the administration of CCH is connected to the observed complications, physicians should recognize the potential for serious rare complications in any treatment of Dupuytren contracture.
机译:>背景:胶原酶组织溶梭状芽孢杆菌(CCH)注射和操作是一种治疗Dupuytren挛缩症的相对较新的方法,这种方法越来越流行。尽管诸如肿胀和瘀斑等副作用很常见,但它们通常是轻度的并且自我限制。主要并发症很少见,但包括屈肌腱断裂和复杂的局部疼痛综合征。 >方法:该研究描述了我院2例患者的病例报告。 >结果:在这里,我们报告2例在我们机构看过的患者,每例患者在CCH注射和操作后都有不同但严重的并发症。一名患者皮肤大量脱落,选择截肢术而不是重建术。另一例患者有灌注不足,需要截肢。 >结论:尽管尚不清楚CCH的给药与所观察到的并发症有多直接联系,但医生应认识到在治疗Dupuytren挛缩症时严重罕见并发症的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号